Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Persistent Reversal of Enhanced Amphetamine Intake by Transient CaMKII Inhibition

Persistent Reversal of Enhanced Amphetamine Intake by Transient CaMKII Inhibition

Thumbnail Image
Download
Name

Loweth-2013-Persistent Reversal.pdf

Size

962.96 KB

Format

Adobe PDF

Checksum (MD5)

130802674df27601743dd51ec649e2d4

Author(s)
Loweth, Jessica A.
•
Li, Dongdong
•
Cortright, James J.
•
Wilke, Georgia
•
Jeyifous, Okunola
•
Neve, Rachael L.
•
Bayer, K. Ulrich
•
Vezina, Paul
Date Issued
January 2013
Journal
Journal of Neuroscience
Publisher
Society for Neuroscience
Citation
Loweth, J. A., D. Li, J. J. Cortright, G. Wilke, O. Jeyifous, R. L. Neve, K. U. Bayer, and P. Vezina. “Persistent Reversal of Enhanced Amphetamine Intake by Transient CaMKII Inhibition.” Journal of Neuroscience 33, no. 4 (January 23, 2013): 1411-1416.
Version
Final published version
Abstract
Amphetamine exposure transiently increases Ca2+/calmodulin-dependent protein kinase II (CaMKII) α expression in the nucleus accumbens (NAcc) shell and this persistently increases local GluA1 S831 phosphorylation and enhances behavioral responding to the drug. Here we assessed whether transiently interfering with CaMKII signaling using a dominant-negative CaMKIIα mutant delivered to the NAcc shell with herpes simplex viral vectors could reverse these long-lasting biochemical and behavioral effects observed following exposure to amphetamine. As expected, transient expression of CaMKIIα K42M in the NAcc shell produced a corresponding transient increase in CaMKIIα and decrease in pCaMKIIα (T286) protein levels in this site. Remarkably, this transient inhibition of CaMKII activity produced a long-lasting reversal of the increased GluA1 S831 phosphorylation levels in NAcc shell and persistently blocked the enhanced locomotor response to and self-administration of amphetamine normally observed in rats previously exposed to the drug. Together, these results indicate that even transient interference with CaMKII signaling may confer long-lasting benefits in drug-sensitized individuals and point to CaMKII and its downstream pathways as attractive therapeutic targets for the treatment of stimulant addiction.
MIT Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/79759
DOI of Published Version
https://doi.org/10.1523/jneurosci.4386-13.2013
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.